SMARCA4 and triple-negative breast carcinoma: However, PFI-3, unlike BRG1 knockdown, did not change the proliferation rate of triple negative breast cancer cells at any concentration (Figure 2A), nor did it displace BRG1 from chromatin at specific gene loci (Supplemental Figure 4).